November 2016
  • Fundraising
  • -
  • Equity capital markets

Founded in 2010 in Belgium, PHARMASIMPLE is a pure player in the online OTC pharmacy market. PHARMASIMPLE is a leading player in this market in France and in Benelux with already 300,000 referenced customers and one of the largest offers on the market.

Driven by its growth, and the pharmaceutical expertise of its founding directors and a structured team, PHARMASIMPLE’s ambition is to become one of the leaders in France and in Europe.

Since its creation in 2010, PHARMASIMPLE has been supporting its hypergrowth model by preserving a positive EBITDA. PHARMASIMPLE generated a revenue of € 6.8M in 2015, an increase of 51% from 2014, with an EBITDA of € 148K.

ATOUT CAPITAL accompanied PHARMASIMPLE for the listing of its securities on Free Market of EURONEXT Paris under the direct listing procedure. 30,000 shares, representing 3.2 % of its share capital, were offered to the market. The demand was significant, with a service rate lower than 100%. PHARMASIMPLE shares have been listed since November 17th 2016 (ISIN BE0974302342/Ticker: MLPHA).

This first step should allow PHARMASIMPLE to settle into the stock markets before a further fund raising aiming to finance its growth and to prepare its transfer to Alternext.

ATOUT CAPITAL (under CIF No. E 001758 filed with the FMA) is a French independent corporate finance adviser dedicated to SMEs. It specializes in Equity Financing operations (IPO, private placements, secondary offerings), M&A (tender offers, industrial operations, LBO), and Debt Financing operations (IBO, bank and private debts) and insolvency proceedings.

Can we help you?
In both public and private companies, Atout Capital is able
to provide a unique transversal expertise with a 360 degree approach.